<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Cell Int</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Cell Int</journal-id><journal-id journal-id-type="pmc-domain-id">96</journal-id><journal-id journal-id-type="pmc-domain">cancell</journal-id><journal-title-group><journal-title>Cancer Cell International</journal-title></journal-title-group><issn pub-type="epub">1475-2867</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10422805</article-id><article-id pub-id-type="pmcid-ver">PMC10422805.1</article-id><article-id pub-id-type="pmcaid">10422805</article-id><article-id pub-id-type="pmcaiid">10422805</article-id><article-id pub-id-type="pmid">37568237</article-id><article-id pub-id-type="doi">10.1186/s12935-023-03011-8</article-id><article-id pub-id-type="publisher-id">3011</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2271-670X</contrib-id><name name-style="western"><surname>Farhadi</surname><given-names initials="A">Ali</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4552-8362</contrib-id><name name-style="western"><surname>Abuei</surname><given-names initials="H">Haniyeh</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2137-1428</contrib-id><name name-style="western"><surname>Okhovat</surname><given-names initials="MA">Mohammad Ali</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4867-5686</contrib-id><name name-style="western"><surname>Geramizadeh</surname><given-names initials="B">Bita</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5917-920X</contrib-id><name name-style="western"><surname>Behzad-Behbahani</surname><given-names initials="A">Abbas</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8229-3593</contrib-id><name name-style="western"><surname>Chong</surname><given-names initials="PP">Pei Pei</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3588-2448</contrib-id><name name-style="western"><surname>Nikouyan</surname><given-names initials="N">Negin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1461-3054</contrib-id><name name-style="western"><surname>Namdari</surname><given-names initials="S">Sepide</given-names></name><address><email>namdarisepide@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01n3s4692</institution-id><institution-id institution-id-type="GRID">grid.412571.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8819 4698</institution-id><institution>Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, </institution><institution>Shiraz University of Medical Sciences, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01n3s4692</institution-id><institution-id institution-id-type="GRID">grid.412571.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8819 4698</institution-id><institution>Department of Medical Laboratory Sciences, School of Paramedical Sciences, </institution><institution>Shiraz University of Medical Sciences, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.412571.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8819 4698</institution-id><institution>Department of Pathology, </institution><institution>Medical School of Shiraz University, Shiraz University of Medical Sciences, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01n3s4692</institution-id><institution-id institution-id-type="GRID">grid.412571.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8819 4698</institution-id><institution>Transplant Research Center, </institution><institution>Shiraz University of Medical Sciences, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0498pcx51</institution-id><institution-id institution-id-type="GRID">grid.452879.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 0003</institution-id><institution>School of Biosciences, Faculty of Health and Medical Sciences, </institution><institution>Taylor&#8217;s University, </institution></institution-wrap>Subang Jaya, Malaysia </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">425437</issue-id><elocation-id>166</elocation-id><history><date date-type="received"><day>2</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>13</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-02-11 22:25:10.350"><day>11</day><month>02</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12935_2023_Article_3011.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">There exists strong evidence that human papillomavirus (HPV) is associated with cervical cancer (CC). HPV E6 is a major oncogene whose sequence variations may be associated with the development of CC. There is not sufficient data on the distribution of HPV types in ThinPrep cytology specimens and HPV 16/18 E6 gene variations among CC patients in the southwest of Iran. This study was conducted to contribute to HPV screening and vaccination in Iran.</p></sec><sec><title>Methods</title><p id="Par2">A total of 648 women screened for cervicitis, intraepithelial neoplasia or CC were included in the study. All participants underwent ThinPrep cytology testing, single-step HPV DNA detection and allele-specific reverse hybridization assays. Moreover, a total of 96 specimens previously tested positive for single infection with HPV16 or 18 were included for variant analysis. HPV16/18 lineages and sublineages were determined by PCR assays followed by sequencing the E6 gene and the construction of neighbor-joining phylogenetic trees.</p></sec><sec><title>Results</title><p id="Par3">Overall, HPV DNA was detected in 62.19% of all the screened subjects. The detection rates of HPV DNA among individuals with normal, ASC-US, ASC-H, LSIL, and HSIL cervical cytology were 48.9%, 93.6%, 100%, 100%, and 100%, respectively. Low-risk HPVs were detected more frequently (46.9%) than high-risk (38.9%) and possible high-risk types (11.1%). Of 403 HPV-positive subjects, 172 (42.7%) had single HPV infections while the remaining 231 (57.3%) were infected with multiple types of HPV. Our results indicated a remarkable growth of high-risk HPV66 and 68 and low-risk HPV81 which have rarely been reported in Iran and HPV90 and 87 that are reported for the first time in the country. In addition, 3 lineages (A, D, and C) and 6 sublineages (A1, A2, A4, C1, D1, and D2) of HPV16, and one lineage and 4 sublineages (A1, A3, A4, and A5) of HPV18 were identified. The studied HPV16 and 18 variants mainly belonged to the D1 and A4 sublineages, respectively.</p></sec><sec><title>Conclusion</title><p id="Par4">The present study suggests that the prevalence of HPV infection in women of all age groups with or without premalignant lesions in the southwestern Iran is high and the predominant HPV types in the southwest of Iran may differ from those detected in other parts of the country. This study also highlights the necessity of not only initiating HPV vaccination for the general population but also developing new vaccines that confer immunity against the prevalent HPV types in the area and national cervical screening programs using a combination of thinPrep cytology test and HPV detection assays in order to&#160;improve the accuracy of the screening.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12935-023-03011-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>HPV</kwd><kwd>ThinPrep</kwd><kwd>Phylogenetic analysis</kwd><kwd>Lineage</kwd><kwd>HPV16</kwd><kwd>HPV18</kwd><kwd>Cervical cancer</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par19">Known as the fourth most common gynecological malignancy, cervical cancer (CC) was reported to account for about 604,000 new cases and approximately 342,000 deaths across the world in the year 2020 [<xref ref-type="bibr" rid="CR1">1</xref>]. The incidence rate of CC is increasing in Iran and has been estimated to be 4.5 per 100,000 women [<xref ref-type="bibr" rid="CR2">2</xref>]. Annually, one out of every 123 women develops CC and nine out of every 100,000 women die of this disease [<xref ref-type="bibr" rid="CR3">3</xref>]. Persistent human papillomavirus (HPV) infection is known to be the primary cause of CC as well as the preceding premalignant lesions referred to as cervical intraepithelial neoplasia (CIN) [<xref ref-type="bibr" rid="CR4">4</xref>]. The development of CC from CIN takes place through a long reversible process. Timely diagnosis and intervention during this process can reduce the risk of CC occurrence [<xref ref-type="bibr" rid="CR5">5</xref>]. There exist 51 recognized HPV types that are classified into three distinct risk groups based on their association with CC. High-risk HPV (HR-HPV) types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) are known to have great carcinogenic potential. Possible high-risk (pHR-HPV) types (26, 53, 67, 70, 73, and 82) are suspected of carcinogenesis but whether they are indeed associated with CC or not is yet to be proved. Low-risk HPV (LR-HPV) types (6, 7, 11, 13, 30, 32, 34, 40, 42, 43, 44, 54, 61, 62, 69, 71, 72, 74, 81, 83, 84, 85, 86, 87, 89, 90, 91, 97, 102, 106, and 114), on the other hand, are generally responsible for non-cancerous genital lesions [<xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par20">Proper management of CC relies on early diagnosis and effective prophylactic vaccination [<xref ref-type="bibr" rid="CR9">9</xref>]. There are HPV vaccines, such as GARDASIL<sup>&#174;</sup>9, that target most of the HR-HPVs. However, not only has not HPV vaccination&#160;been included in the national vaccination program in Iran, but also the vaccines that are available in the market are only protective against HPV16 and 18. Furthermore, since the prevalence of HPV types varies by geographic region [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], the distribution pattern of HPV types should be considered to select the most effective HPV vaccine for different populations as well as different age groups [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par21">HPV types are classified into different lineages provided that there is a difference of 1%-10% in complete genomic nucleotide sequences, and further into different sublineages in case of 0.5%-1% sequence variation, allowing better identification of viral heterogeneity [<xref ref-type="bibr" rid="CR13">13</xref>]. HPV16 variants have been classified into four principal lineages based on sequences published by Burk et al. [<xref ref-type="bibr" rid="CR13">13</xref>], and also presented in the Papillomavirus Episteme database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pave.niaid.nih.gov">http://pave.niaid.nih.gov</ext-link>). These lineages are as follows; lineage A, including sublineages A1&#8211;A3 (previously known as European variants) and A4 (previously known as Asian variant); lineage B, comprising sublineages B1, B2 (formerly known as African-1 variants), B3, and B4; lineage C, with sublineage C1 (formerly African-2 variant), C2, C3, and C4; and lineage D, consisting of sublineages D1 (previously North American variant), D2, D3 (Asian&#8211;American variants), and D4. Moreover, HPV18 variants have been classified into three main lineages: lineage A, including sublineages A1, A2 (previously known as Asian Amerindian variants), and A3&#8211;A5 (formerly known as European variants); lineage B, with sub-lineages B1&#8211;B3, and lineage C with the only sub-lineage named C1 (all previously known as African variants) [<xref ref-type="bibr" rid="CR13">13</xref>]. According to epidemiological findings, HPV16 variants pose the risk of persistent infection, progression to pre-cancer, and cancer. Furthermore, HPV16 sublineages A3, A4, and D have been reported to be associated with higher risks of CC [<xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>]. Conversely, most studies do not support any of HPV18 lineages or sublineages carrying a higher risk of cancer compared to others [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. However, these findings were not replicated globally and the inconsistent results highlight the necessity of further studies on the distribution of HPV16/18 lineages and sublineages in different regions and their oncogenicity considering ethnicity.</p><p id="Par22">Undoubtedly, regional data on the prevalence and type distribution of HPVs are of great importance to evaluate the potential of currently available HPV vaccines to prevent CC. In addition, the knowledge of HPV type distribution in each country is pivotal to vaccine development and national vaccination programming. Although there are many reports on the distribution of different HPV types and variants worldwide, there seem to be few regional studies investigating the distribution pattern of HPV types [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] and HPV16/18 variants in the Iranian population [<xref ref-type="bibr" rid="CR21">21</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>]. Previous studies in Iran have reported the prevalence of HPV in different cervical specimens to range from 5.5% to 9.4% in normal cytology specimens [<xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref>]; between 61.7% and 65.3% in CIN I&#8211;III samples [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], and between 75.2% and 87% in CC specimens [<xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR32">32</xref>]. However, regardless of cervical cytology result, the overall prevalence of HPV infection was reported to be 52.25% in female outpatients referred to the laboratories of Tehran, the capital&#160;of Iran, between 2019 and 2021. The rate of HR-HPV and LR-HPV types among these patients were 42.1% and 57.9%, respectively [<xref ref-type="bibr" rid="CR33">33</xref>]. Herein, we have examined the type-specific prevalence of HPVs&#160;with a large sample size and further investigated the E6 gene-based genetic variability of HPV16/18 lineages and sublineages according to the severity of the cervical lesions in the southwest of Iran.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study subjects</title><p id="Par23">A total of 722 women who attended the outpatient office of Shahid Motahari Gynecology Clinic, a reference center affiliated with Shiraz University of Medical Sciences, Shiraz, Iran to be screened for cervicitis, intraepithelial neoplasia or CC from February 2018 to November 2021 were considered for inclusion in the study. After being informed of the research goals, the participants voluntarily completed a series of examinations consisting of ThinPrep cytology test and HPV DNA detection and typing&#160;assay. All participants were aged between 16 and 75 years old and met the inclusion criterion of having a history of sexual intercourse. Further, (1) pregnant women or those who had terminated their pregnancy within 3 months prior to the study, (2) those with mental disorders, (3) vaginal, cervical or uterine hemorrhage, (4) acute infections of lower genital tract, vulva, vagina or cervix, (5) concurrent sexually transmitted diseases, and (6) full or&#160;partial HPV vaccination were excluded from the study. Finally, 648 participants were identified as qualified for the study. Moreover, a total of 96 specimens previously screened for HPV infection, including 48 with HPV16 single infection and 48 with HPV18 single infection, were included in the study for variant analysis. Each group consisted of 12 normal, 12 low-grade squamous intraepithelial lesion (LSIL), 12 high-grade squamous intraepithelial lesion (HSIL), and 12 CC specimens. Premalignant/malignant samples in the mentioned groups were formalin-fixed paraffin-embedded (FFPE) tissue biopsies whereas the normal ones were ThinPrep Pap Test specimens. Hematoxylin&#8211;eosin staining was performed for all specimens and the diagnoses were confirmed by experienced pathologist.</p></sec><sec id="Sec4"><title>ThinPrep cytology testing</title><p id="Par24">For cytology examination, ThinPrep liquid-based cytology samples were referred by physicians to the laboratory based on standard CC screening methodology. Briefly, a sampling brush was used to collect exfoliated cells at the cervical canal and the external aperture of the cervix. Collected cells were stored in a preservation solution. Using a ThinPrep 2000 system, a thin-layer cell smear was prepared for Pap examination. Grading was carried out based on the Bethesda criteria [<xref ref-type="bibr" rid="CR34">34</xref>] as follows: (I) no intraepithelial lesion or malignancy (NILM); (II) abnormality of squamous epithelial cell including: a, atypical squamous cells (ASCs), consisting of ASCs of undetermined significance (ASC-US) and ASCs that cannot exclude high-grade squamous intraepithelial lesion (ASC-H); b, low-grade squamous intraepithelial lesion (LSIL); c, high-grade squamous intraepithelial lesion (HSIL); and d, squamous cell carcinoma (SCC); 3) glandular epithelial cell abnormality including: a, atypical glandular cells (AGCs), consisting of AGC not otherwise specified (AGC-NOS) and AGC suspicious for neoplasia (AGC-N); b, cervical adenocarcinoma in situ of the cervical canal (AIS); and c, adenocarcinoma (ADC); and 4) other malignant tumors.</p></sec><sec id="Sec5"><title>DNA extraction</title><p id="Par25">ThinPrep media containing suspended cells were mixed by inversion and 500 &#181;l-aliquots were separated for DNA extraction using QIAamp DNA mini kit (Qiagen, Hilden, Germany). In the case of FFPE tissue specimens, four 5-&#956;m-thick slices were cut and collected in autoclaved Eppendorf microtubes for each patient. Only one case was sectioned at a time; the microtome blade was changed and the workplace was cleaned with ethanol thoroughly along with the microtome between every two cases to prevent contamination. Furthermore, paraffin blocks without tissue were cut after every real specimen and served as negative controls of DNA extraction process. DNA was extracted from FFPE tissue specimens using QIAamp DNA FFPE Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer&#8217;s instruction. The concentration of the extracted DNA was measured by a NanoDrop (ND-1000) spectrophotometer (peQLab Biotechnologie, Erlangen, Germany). All DNA specimens were stored at&#8201;&#8722;&#8201;70 &#176;C until required.</p></sec><sec id="Sec6"><title>HPV detection and typing</title><p id="Par26">For HPV DNA detection and genotyping in ThinPrep cytology specimens, the AMPLIQUALITY HPV-TYPE EXPRESS v3.0 (Code: 03-35A-20 M AB, Analitica, Italy) method was used which is based on the amplification of L1 viral region&#160;in a Single-Step PCR followed by Reverse Line Blot assay. This method allows the identification of 40 HPV types: 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68 (a e b), 69, 70, 71, 72, 73, 81, 82, 83, 84, 87, 89, and 90 and uses the dUTP/UNG system for the prevention of carry-over contamination. Negative controls (5 &#956;l of sterile water instead of DNA) and positive controls (5 &#956;l of the positive control provided in the kit) were included in each PCR run. All procedures were performed according to the manufacturers' instructions. All tests were interpreted manually by two independent readers. A third reader was used in case of disagreement between the results.</p></sec><sec id="Sec7"><title>Determination of HPV16 and 18 lineages and sublineages and phylogenetic analysis</title><p id="Par27">Primer sets HPV16-E6-F/HPV16-E6-R and HPV18-E6-F/HPV18-E6-R were used for the amplification of full-length HPV16/18 E6 gene in the DNA samples extracted from the FFPE tissue specimens that had previously tested positive for single infections with either HPV16 or 18 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The amplification of HPV16/18 E6 gene was performed in a 50-&#956;l reaction mixture containing 500 ng of DNA template, 0.5 &#181;M of each primer, and TEMPase Hot Start DNA Polymerase 2&#8201;&#215;&#8201;Master Mix (Ampliqon, Odense, Denmark). PCR amplification cycles included an initial 15-min denaturation at 95 &#176;C, followed by 40 cycles of 95 &#176;C for 45 s, 55 &#176;C for 1 min, and 72 &#176;C for 1 min, and a final elongation at 72 &#176;C for 5 min. A reaction mixture without template DNA, as a negative control, was included in every PCR run. Plasmids containing HPV16 and HPV18 DNA cloned in pBluescript (Manassas, VA, USA) and pBR322 (Manassas, VA), respectively, which were available from a previous study [<xref ref-type="bibr" rid="CR35">35</xref>], were used as positive controls.</p><p id="Par28">Since using HPV16 E6 G433 and A532 nucleotide&#160;sequences could not distinguish between D1 and D4 sublineages, all HPV16 isolates which belonged to the D1/D4 sublineages were further analyzed by PCR assay using 16LCR-F/16LCR-R primer set for the amplification of HPV16 long control region (LCR) according to the previously published protocol [<xref ref-type="bibr" rid="CR36">36</xref>] (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The single nucleotide polymorphism (SNP) C7781T was considered as a diagnostic criterion for differentiation between D1 and D4 sublineages. The specific detection of D1 sublineage was achieved by observing the following six SNP variations: G145T, T286A, A289G, C335T, T350G, and C7781T.</p><p id="Par29">Following visualization on 1.5% agarose gel, the bands of generated amplicons were excised and purified using GF-1 PCR Clean-Up Kit (Vivantis, Malaysia) and were subsequently subjected to sequencing (Sequetech Corp.,Mountain View, CA, USA) in both directions. The obtained sequences are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link> with GenBank accession numbers from <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide-range" xlink:href="OP572427:OP572522">OP572427 to OP572522</ext-link>. All the sequences were analyzed using BLAST software program (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.blast.ncbi.nlm.nih.gov/blast/html">http://www.blast.ncbi.nlm.nih.gov/blast/html</ext-link>) and classified into lineages and sublineages according to the prototype reference sequences given in the Papillomavirus Episteme database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pave.niaid.nih.gov">http://pave.niaid.nih.gov</ext-link>). Phylogenetic trees were generated using maximum-likelihood method Mega software version 7 [<xref ref-type="bibr" rid="CR37">37</xref>], and the sublineages were identified based on 0.5&#8211;1.0% differences between isolate genomes. Reference HPV16 E6 sequences that were used to construct the phylogenetic branches were collected from the GenBank sequence database and included <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="K02718">K02718</ext-link> (A1), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AF536179">AF536179</ext-link> (A2), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="HQ644236">HQ644236</ext-link> (A3), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AF534061">AF534061</ext-link> (A4), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AF536180">AF536180</ext-link> (B1), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="HQ644298">HQ644298</ext-link> (B2), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KU053910">KU053910</ext-link> (B3), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KU053914">KU053914</ext-link> (B4), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AF472509">AF472509</ext-link> (C1), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="HQ644244">HQ644244</ext-link> (C2), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KU053921">KU053921</ext-link> (C3), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KU053922">KU053922</ext-link> (C4), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="HQ644257">HQ644257</ext-link> (D1), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AY686579">AY686579</ext-link> (D2), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AF402678">AF402678</ext-link> (D3), and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KU053933">KU053933</ext-link> (D4). Furthermore, in the case of phylogenetic branches for HPV18 E6 gene, reference sequences obtained from the GenBank database included <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AY262282.1">AY262282.1</ext-link> (A1), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="EF202146">EF202146</ext-link> (A2), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="EF202147">EF202147</ext-link> (A3), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="EF202151">EF202151</ext-link> (A4), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="GQ180787">GQ180787</ext-link> (A5), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="EF202155">EF202155</ext-link> (B1), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KC470225">KC470225</ext-link> (B2), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="EF202152">EF202152</ext-link> (B3), and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KC470229">KC470229</ext-link> (C1). The robustness of the phylogenetic trees was assessed using 1000 bootstrap repetitions. Furthermore, nucleotide sequences were translated by ExPASy (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://web.expasy.org/translate/">http://web.expasy.org/translate/</ext-link>) for the determination of amino acid changes.</p></sec><sec id="Sec8"><title>Statistical analysis</title><p id="Par30">Data were analyzed using SPSS version 21.0 (SPSS Institute, Chicago, IL, USA). Chi-square test or two-sided Fisher&#8217;s exact test was used to analyze the potential association of HPV PCR results, HPV types, and lineages with age, cervical pre-neoplastic lesions, CC, and other categorical factors, where appropriate. p-values less than 0.05 were considered to be statistically significant.</p></sec></sec><sec id="Sec9"><title>Results</title><sec id="Sec10"><title>Prevalence and distribution of HPV types</title><p id="Par31">Totally, 648 female participants were included in the study with ages ranging from 16 to 75 years (mean&#8201;&#177;&#8201;SD&#8201;=&#8201;33.83&#8201;&#177;&#8201;8.74). Of all the screened subjects, 403 (62.19%) were found to be positive for HPV DNA. HPV typing revealed 33 types among the studied samples. A representative HPV genotyping test strip is provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig.&#160;S1. Those included 14 HR-HPVs (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), 4 pHR-HPVs (HPV53, 67, 73, 82), and 15 LR-HPVs genotypes (HPV6, 11, 40, 42, 43, 44, 54, 61, 62, 81, 83, 84, 87, 89, 90). The distribution of different HPV types among HPV-positive individuals is presented in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. The most prevalent HR-HPV type was HPV16 which was detected in 17.6% of HPV-positive cases. Furthermore, HPV6 was found to be the most common LR-HPV type detected in 45.6% of HPV-positive individuals.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Prevalence of HPV types among HPV-positive individuals</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12935_2023_3011_Fig1_HTML.jpg"/></fig></p><p id="Par32">The detection rates of HPV testing among individuals with normal, ASC-US, ASC-H, LSIL, and HSIL cervical cytology were 48.9%, 93.6%, 100%, 100% and 100%, respectively (Table <xref rid="Tab1" ref-type="table">1</xref>). The frequency of HPV infection was significantly higher among participants with abnormal cervical cytology than that among individuals with normal cervical cytology (p&#8201;&lt;&#8201;0.0001). The distribution of HR-HPV, pHR-HPV, and LR-HPV types in different cervical cytology groups is presented in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Distribution of HPV infection, HPV risk groups, and single/multiple HPV infections among individuals with different cervical cytology grades</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="5" rowspan="1">Cervical cytology</th><th align="left" colspan="1" rowspan="1">P-value</th></tr><tr><th align="left" colspan="1" rowspan="1">Normal</th><th align="left" colspan="1" rowspan="1">ASC-US</th><th align="left" colspan="1" rowspan="1">ASC-H</th><th align="left" colspan="1" rowspan="1">LSIL</th><th align="left" colspan="1" rowspan="1">HSIL</th><th align="left" colspan="1" rowspan="1"/></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="6" rowspan="1">N (%)</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>HPV test</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;HPV positive</td><td align="left" colspan="1" rowspan="1">229 (48.9)</td><td align="left" colspan="1" rowspan="1">88 (93.6)</td><td align="left" colspan="1" rowspan="1">42 (100)</td><td align="left" colspan="1" rowspan="1">28 (100)</td><td align="left" colspan="1" rowspan="1">16 (100)</td><td align="left" rowspan="2" colspan="1">P&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;HPV negative</td><td align="left" colspan="1" rowspan="1">239 (51.1)</td><td align="left" colspan="1" rowspan="1">6 (6.4)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Risk group</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;High-risk only</td><td align="left" colspan="1" rowspan="1">35 (15.3)</td><td align="left" colspan="1" rowspan="1">12 (13.6)</td><td align="left" colspan="1" rowspan="1">12 (28.6)</td><td align="left" colspan="1" rowspan="1">8 (28.6)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" rowspan="4" colspan="1">P&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Possible high-risk only</td><td align="left" colspan="1" rowspan="1">12 (5.2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Low-risk only</td><td align="left" colspan="1" rowspan="1">135 (59.0)</td><td align="left" colspan="1" rowspan="1">2 (2.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Multiple risk groups</td><td align="left" colspan="1" rowspan="1">47 (20.5)</td><td align="left" colspan="1" rowspan="1">74 (84.1)</td><td align="left" colspan="1" rowspan="1">30 (75.0)</td><td align="left" colspan="1" rowspan="1">20 (71.4)</td><td align="left" colspan="1" rowspan="1">16 (100)</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Single/multiple infection</bold></td><td align="left" colspan="6" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Single infection</td><td align="left" colspan="1" rowspan="1">153 (66.8)</td><td align="left" colspan="1" rowspan="1">8 (9.1)</td><td align="left" colspan="1" rowspan="1">7 (16.7)</td><td align="left" colspan="1" rowspan="1">4 (14.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" rowspan="9" colspan="1">P&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Double infection</td><td align="left" colspan="1" rowspan="1">51 (22.3)</td><td align="left" colspan="1" rowspan="1">38 (43.2)</td><td align="left" colspan="1" rowspan="1">12 (28.6)</td><td align="left" colspan="1" rowspan="1">5 (17.9)</td><td align="left" colspan="1" rowspan="1">1 (6.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Triple infection</td><td align="left" colspan="1" rowspan="1">16 (7.0)</td><td align="left" colspan="1" rowspan="1">27 (30.7)</td><td align="left" colspan="1" rowspan="1">19 (45.2)</td><td align="left" colspan="1" rowspan="1">7 (25.0)</td><td align="left" colspan="1" rowspan="1">5 (31.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Quadruple infection</td><td align="left" colspan="1" rowspan="1">3 (1.3)</td><td align="left" colspan="1" rowspan="1">9 (10.2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">5 (17.9)</td><td align="left" colspan="1" rowspan="1">3 (18.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Quintuple infection</td><td align="left" colspan="1" rowspan="1">5 (2.2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (7.1)</td><td align="left" colspan="1" rowspan="1">1 (3.6)</td><td align="left" colspan="1" rowspan="1">4 (25.0)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Sextuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (3.4)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">2 (7.1)</td><td align="left" colspan="1" rowspan="1">3 (18.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Septuple infection</td><td align="left" colspan="1" rowspan="1">1 (0.4)</td><td align="left" colspan="1" rowspan="1">1 (1.1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (10.7)</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Octuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (1.1)</td><td align="left" colspan="1" rowspan="1">1 (2.4)</td><td align="left" colspan="1" rowspan="1">1 (3.6)</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Decuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (1.1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr></tbody></table></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Distribution of high-risk HPV types (<bold>a</bold>), possible high-risk HPV types (<bold>b</bold>), and low-risk HPV types (<bold>c</bold>) in HPV-positive groups of normal, ASC-US, ASC-H, LSIL, and HSIL cervical cytology</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12935_2023_3011_Fig2_HTML.jpg"/></fig></p><p id="Par33">Of 403 HPV-positive cases, 172 (42.7%) were found to be infected with a single HPV type while the remaining 231 (57.3%) cases were infected with multiple types of HPV. Multiple HPV infections were significantly more frequent among participants with abnormal cervical cytology than those with normal cervical cytology (p&#8201;&lt;&#8201;0.0001). Moreover, the rate of multiple HPV infections was significantly higher among participants aged above 30 years compared to those with&#8201;&#8804;&#8201;30 years of age (p&#8201;=&#8201;0.001). The distribution of single and multiple HPV infections in the groups of different cervical cytology grades and age ranges is presented in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>, respectively.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Distribution of different cervical cytology diagnoses, HPV risk groups, and single/multiple HPV infections in different age groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="7" rowspan="1">Age range</th></tr><tr><th align="left" colspan="1" rowspan="1">&#8201;&#8804;&#8201;20</th><th align="left" colspan="1" rowspan="1">21&#8211;30</th><th align="left" colspan="1" rowspan="1">31&#8211;40</th><th align="left" colspan="1" rowspan="1">41&#8211;50</th><th align="left" colspan="1" rowspan="1">51&#8211;60</th><th align="left" colspan="1" rowspan="1">61&#8211;70</th><th align="left" colspan="1" rowspan="1">71&#8211;80</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="7" rowspan="1">N (%)</td></tr><tr><td align="left" colspan="8" rowspan="1"><bold>Cervical cytology</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Normal</td><td align="left" colspan="1" rowspan="1">16 (88.9)</td><td align="left" colspan="1" rowspan="1">207 (83.1)</td><td align="left" colspan="1" rowspan="1">171 (65.3)</td><td align="left" colspan="1" rowspan="1">55 (67.1)</td><td align="left" colspan="1" rowspan="1">19 (61.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;ASC-US</td><td align="left" colspan="1" rowspan="1">1 (5.6)</td><td align="left" colspan="1" rowspan="1">21 (8.4)</td><td align="left" colspan="1" rowspan="1">57 (21.8)</td><td align="left" colspan="1" rowspan="1">12 (14.6)</td><td align="left" colspan="1" rowspan="1">1 (3.2)</td><td align="left" colspan="1" rowspan="1">2 (100)</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;ASC-H</td><td align="left" colspan="1" rowspan="1">1 (5.6)</td><td align="left" colspan="1" rowspan="1">17 (6.8)</td><td align="left" colspan="1" rowspan="1">14 (5.3)</td><td align="left" colspan="1" rowspan="1">8 (9.8)</td><td align="left" colspan="1" rowspan="1">2 (6.5)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;LSIL</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">4 (1.6)</td><td align="left" colspan="1" rowspan="1">13 (5.0)</td><td align="left" colspan="1" rowspan="1">6 (7.3)</td><td align="left" colspan="1" rowspan="1">5 (16.1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;HSIL</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">7 (2.7)</td><td align="left" colspan="1" rowspan="1">1 (1.2)</td><td align="left" colspan="1" rowspan="1">4 (12.9)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">4 (100)</td></tr><tr><td align="left" colspan="8" rowspan="1"><bold>Risk group</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;High-risk only</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">34 (20.4)</td><td align="left" colspan="1" rowspan="1">21 (12.5)</td><td align="left" colspan="1" rowspan="1">7 (17.9)</td><td align="left" colspan="1" rowspan="1">3 (23.1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Possible high-risk only</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">8 (4.8)</td><td align="left" colspan="1" rowspan="1">4 (2.4)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Low-risk only</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">66 (39.5)</td><td align="left" colspan="1" rowspan="1">56 (33.3)</td><td align="left" colspan="1" rowspan="1">13 (33.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Multiple risk groups</td><td align="left" colspan="1" rowspan="1">8 (66.7)</td><td align="left" colspan="1" rowspan="1">59 (35.3)</td><td align="left" colspan="1" rowspan="1">87 (51.8)</td><td align="left" colspan="1" rowspan="1">19 (48.7)</td><td align="left" colspan="1" rowspan="1">10 (76.9)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">4 (100)</td></tr><tr><td align="left" colspan="8" rowspan="1"><bold>Single/multiple infection</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Single infection</td><td align="left" colspan="1" rowspan="1">4 (33.3)</td><td align="left" colspan="1" rowspan="1">89 (53.3)</td><td align="left" colspan="1" rowspan="1">62 (36.9)</td><td align="left" colspan="1" rowspan="1">15 (38.5)</td><td align="left" colspan="1" rowspan="1">2 (15.4)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Double infection</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">43 (25.7)</td><td align="left" colspan="1" rowspan="1">48 (28.6)</td><td align="left" colspan="1" rowspan="1">12 (30.8)</td><td align="left" colspan="1" rowspan="1">3 (23.1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Triple infection</td><td align="left" colspan="1" rowspan="1">6 (50.0)</td><td align="left" colspan="1" rowspan="1">16 (9.6)</td><td align="left" colspan="1" rowspan="1">40 (23.8)</td><td align="left" colspan="1" rowspan="1">8 (20.5)</td><td align="left" colspan="1" rowspan="1">3 (23.1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (25.0)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Quadruple infection</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">5 (3.0)</td><td align="left" colspan="1" rowspan="1">10 (6.0)</td><td align="left" colspan="1" rowspan="1">2 (5.1)</td><td align="left" colspan="1" rowspan="1">2 (15.4)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Quintuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">5 (3.0)</td><td align="left" colspan="1" rowspan="1">5 (3.0)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (75.0)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Sextuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (1.8)</td><td align="left" colspan="1" rowspan="1">2 (1.2)</td><td align="left" colspan="1" rowspan="1">1 (2.6)</td><td align="left" colspan="1" rowspan="1">2 (15.4)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Septuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (1.8)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (2.6)</td><td align="left" colspan="1" rowspan="1">1 (7.7)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Octuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">2 (1.2)</td><td align="left" colspan="1" rowspan="1">1 (0.6)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Decuple infection</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (0.6)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr></tbody></table></table-wrap></p><p id="Par34">Examining the frequency of HPV types in different cytology groups, we found that individuals infected with at least one high-risk or possible high-risk HPV type comprised a significantly larger proportion of abnormal cervical cytology group compared to the normal cervical cytology group (p&#8201;&lt;&#8201;0.0001). Moreover, among the LR-HPV types, HPV6 was found to be the most frequent in all of the cytology groups having infected 36.2%, 33.3%, 32.1%, and 43.8% of individuals in the ASC-US, ASC-H, LSIL, and HSIL group, respectively. Among the HR-HPV types, HPV16 was the most prevalent type in the ASC-US, ASC-H, and LSIL cytology group with the infection rates of 27.7%, 23.8%, and 46.4%, respectively. Interestingly, in the case of the HSIL group, HPV56 was the most frequent HR-HPV type with an infection rate of 43.75%.</p><p id="Par35">With regard to the frequency of HPV types among single and multiple infection cases, HPV6 was the most common LR-HPV type accounting for 47.1% of single infections and present in 44.6% of multiple infection cases. Furthermore, while HPV16, 18, and 52 were the most frequent HR-HPV types responsible for single HPV infections (9.3%, 4.7%, and 4.7% of single infections respectively), HPV16, 56, and 66 were the most frequently detected HR-HPV types among multiple HPV infection cases (present in 23.8%, 20.8%, and 19.5% of multiple infections respectively). HPV53 was found to be the most common pHR-HPV type among both single (6.4%) and multiple infection cases (14.3%).</p></sec><sec id="Sec11"><title>Genetic&#160;variations of&#160;HPV16 and 18 E6 gene regions</title><p id="Par36">Forty-eight HPV16 and 48 HPV18 isolates of the 96 previously screened cases were sequenced across the E6 gene (nt: 83-559 and nt: 105-581) and compared with the corresponding HPV16 and HPV18 E6 reference sequences of each lineage and sublineage (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S2 and S3) Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs.&#160;S2&#8211;S7 present DNA Sanger sequencing chromatograms showing sequence polymorphisms throughout the E6 gene region of HPV16 and 18. The sublineage analysis&#160;of HPV16 isolates could not distinguish between D1 and D4 based on the HPV16 E6 gene sequences. Therefore, 22 HPV16 isolates were further analyzed by PCR assay for the amplification of HPV16 LCR and&#160;subsequent Sanger sequencing&#160;of the PCR products. Since C7781T SNP was not detected in any of these isolates, they were all sorted into sublineage D1. Overall, 3 lineages (A, D, and C) and 6 sublineages (A1, A2, A4, C1, D1, and D2) of HPV16, and one lineage and 4 sublineages (A1, A3, A4, and A5) of HPV18 were identified (Tables <xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>). The studied HPV16 variants mainly belonged to the D1 sublineage accounting for 45.83% of all HPV16-positive samples, followed by A4 (27.1%), A1 (12.5%), A2 (10.41%), C1 (2.08%), and D2 (2.08%) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>a). HPV18 isolates mostly belonged to A4 sublineage comprising 47.91% of all HPV18-positive samples, followed by A1 (27.1%), A3 (16.66%), and A5 (8.33%) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>b). The distribution of HPV16 and 18 variants in different cervical cytology grades is presented in Table <xref rid="Tab5" ref-type="table">5</xref>. Neither HPV16 (p&#8201;=&#8201;0.214) nor HPV18 variants (p&#8201;=&#8201;0.579) showed any significant differences in their frequency between normal and premalignant/malignant groups.<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Variations of HPV16 E6 gene from patients with different grades of cervical lesions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">No.</th><th align="left" colspan="1" rowspan="1">Grade of cervical lesion</th><th align="left" colspan="1" rowspan="1">Type of variant</th><th align="left" colspan="1" rowspan="1">109</th><th align="left" colspan="1" rowspan="1">131</th><th align="left" colspan="1" rowspan="1">132</th><th align="left" colspan="1" rowspan="1">135</th><th align="left" colspan="1" rowspan="1">143</th><th align="left" colspan="1" rowspan="1">145</th><th align="left" colspan="1" rowspan="1">178</th><th align="left" colspan="1" rowspan="1">183</th><th align="left" colspan="1" rowspan="1">286</th><th align="left" colspan="1" rowspan="1">289</th><th align="left" colspan="1" rowspan="1">295</th><th align="left" colspan="1" rowspan="1">335</th><th align="left" colspan="1" rowspan="1">350</th><th align="left" colspan="1" rowspan="1">403</th><th align="left" colspan="1" rowspan="1">442</th><th align="left" colspan="1" rowspan="1">532</th><th align="left" colspan="1" rowspan="1">Accession number</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Reference</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="K02718">K02718</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572427">OP572427</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C *</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572428">OP572428</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572429">OP572429</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572430">OP572430</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C *</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572431">OP572431</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572432">OP572432</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">C1</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572433">OP572433</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572434">OP572434</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572435">OP572435</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572436">OP572436</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572437">OP572437</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572438">OP572438</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G *</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572439">OP572439</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572440">OP572440</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C *</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572441">OP572441</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572442">OP572442</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572443">OP572443</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572444">OP572444</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211; *</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572445">OP572445</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572446">OP572446</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572447">OP572447</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572448">OP572448</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">23</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572449">OP572449</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">D2</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572450">OP572450</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572451">OP572451</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572452">OP572452</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A2</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572453">OP572453</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A2</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572454">OP572454</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">29</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572455">OP572455</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572456">OP572456</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572457">OP572457</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">32</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572458">OP572458</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572459">OP572459</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">34</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572460">OP572460</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;*</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572461">OP572461</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">36</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572462">OP572462</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">37</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A2</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572463">OP572463</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">38</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">G*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572464">OP572464</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">39</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572465">OP572465</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572466">OP572466</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">41</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572467">OP572467</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;*</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572468">OP572468</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572469">OP572469</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">44</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572470">OP572470</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">45</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572471">OP572471</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">46</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">D1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572472">OP572472</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">47</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A2</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572473">OP572473</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">48</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A2</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572474">OP572474</ext-link></td></tr><tr><td align="left" colspan="3" rowspan="1"><bold>Amino acid substitution</bold></td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">R10G</td><td align="left" colspan="1" rowspan="1">R10G/I</td><td align="left" colspan="1" rowspan="1">K11T</td><td align="left" colspan="1" rowspan="1">Q14D</td><td align="left" colspan="1" rowspan="1">Q14H/D</td><td align="left" colspan="1" rowspan="1">D25E</td><td align="left" colspan="1" rowspan="1">I27R</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">D64E</td><td align="left" colspan="1" rowspan="1">H78Y</td><td align="left" colspan="1" rowspan="1">L83V</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">E113D</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>The numbers refer to the positions of the nucleotides according to the reference sequence (GenBank accession number <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="K02718">K02718</ext-link>). Nucleotide positions in E6 are presented at the top of the table according to the reference sequence. Nucleotide changes are shown by the corresponding letters. Dashes indicate positions at which no variation was found. Amino acid sequence variations are shown at the bottom; amino acid changes whose codons contain more than one nucleotide replacement are marked with /. Asterisks represent the new SNPs detected in the studied HPV16 isolates</p><p><italic toggle="yes">ADC</italic> adenocarcinoma/adenosquamous carcinoma, <italic toggle="yes">CIN</italic> cervical intraepithelial neoplasia, <italic toggle="yes">LSIL</italic> low-grade squamous intraepithelial lesion, <italic toggle="yes">HSIL</italic> high-grade squamous intraepithelial lesion, <italic toggle="yes">SCC</italic> squamous cell carcinoma, <italic toggle="yes">HPV</italic> human papillomavirus</p></table-wrap-foot></table-wrap><table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Variations of HPV18 E6 gene from patients with different grades of cervical lesions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">No.</th><th align="left" colspan="1" rowspan="1">Grade of cervical lesion</th><th align="left" colspan="1" rowspan="1">Type of variant</th><th align="left" colspan="1" rowspan="1">104</th><th align="left" colspan="1" rowspan="1">149</th><th align="left" colspan="1" rowspan="1">153</th><th align="left" colspan="1" rowspan="1">232</th><th align="left" colspan="1" rowspan="1">287</th><th align="left" colspan="1" rowspan="1">317</th><th align="left" colspan="1" rowspan="1">377</th><th align="left" colspan="1" rowspan="1">382</th><th align="left" colspan="1" rowspan="1">485</th><th align="left" colspan="1" rowspan="1">549</th><th align="left" colspan="1" rowspan="1">554</th><th align="left" colspan="1" rowspan="1">Accession number</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Reference</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">T</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AY262282">AY262282</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572475">OP572475</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572476">OP572476</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572477">OP572477</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572478">OP572478</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572479">OP572479</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572480">OP572480</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572481">OP572481</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572482">OP572482</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572483">OP572483</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572484">OP572484</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572485">OP572485</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">Normal</td><td align="left" colspan="1" rowspan="1">A5</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572486">OP572486</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572487">OP572487</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572488">OP572488</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572489">OP572489</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572490">OP572490</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">T*</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572491">OP572491</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572492">OP572492</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572493">OP572493</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572494">OP572494</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572495">OP572495</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572496">OP572496</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">23</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572497">OP572497</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">LSIL/CIN1</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572498">OP572498</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572499">OP572499</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572500">OP572500</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572501">OP572501</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572502">OP572502</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">29</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572503">OP572503</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572504">OP572504</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572505">OP572505</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">32</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572506">OP572506</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572507">OP572507</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">34</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572508">OP572508</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A5</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">T*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572509">OP572509</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">36</td><td align="left" colspan="1" rowspan="1">HSIL/CIN2-3</td><td align="left" colspan="1" rowspan="1">A5</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;*</td><td align="left" colspan="1" rowspan="1">&#8211;*</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572510">OP572510</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">37</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A1</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572511">OP572511</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">38</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572512">OP572512</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">39</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572513">OP572513</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572514">OP572514</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">41</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572515">OP572515</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572516">OP572516</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">SCC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572517">OP572517</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">44</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572518">OP572518</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">45</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A3</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572519">OP572519</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">46</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572520">OP572520</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">47</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572521">OP572521</ext-link></td></tr><tr><td align="left" colspan="1" rowspan="1">48</td><td align="left" colspan="1" rowspan="1">ADC</td><td align="left" colspan="1" rowspan="1">A5</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">C</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572522">OP572522</ext-link></td></tr><tr><td align="left" colspan="3" rowspan="1"><bold>Amino acid substitution</bold></td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">E33G</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">F71L</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">L93R</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>The numbers refer to the positions of the nucleotides according to the reference sequence (GenBank accession number <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AY262282">AY262282</ext-link>). Nucleotide positions in E6 are presented at the top of the table according to the reference sequence. Nucleotide changes are shown by the corresponding letters. Dashes indicate positions at which no variation was found. Amino acid sequence variations are shown at the bottom; amino acid changes whose codons contain more than one nucleotide replacement are marked with /. Asterisks&#160;represent the new SNPs detected in the studied HPV18 isolates</p><p><italic toggle="yes">ADC</italic> adenocarcinoma/adenosquamous carcinoma, <italic toggle="yes">CIN</italic> cervical intraepithelial neoplasia, <italic toggle="yes">LSIL</italic> low-grade squamous intraepithelial lesion, <italic toggle="yes">HSIL</italic> high-grade squamous intraepithelial lesion, <italic toggle="yes">SCC</italic> squamous cell carcinoma, <italic toggle="yes">HPV</italic> human papillomavirus</p></table-wrap-foot></table-wrap><fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Phylogenetic analysis of HPV16 E6 (<bold>a</bold>) and HPV18 E6 (<bold>b</bold>) gene regions was conducted using the maximum-likelihood method based on the Kimura 2-parameter model with bootstrap resampling (1000 replicates) by the MEGA 6 package [<xref ref-type="bibr" rid="CR37">37</xref>]. Numbers above the branches indicate the bootstrap values. Ninety-six&#160;different nucleotide patterns of studied sequences were indicated by black triangles (GenBank accession numbers <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572427">OP572427</ext-link> through <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572474">OP572474</ext-link> for HPV16 and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572475">OP572475</ext-link> through <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP572522">OP572522</ext-link> for HPV18). The accession number of reference sequences of each sublineage used for phylogenetic analysis in this study was indicated by white triangles</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e5091" position="float" orientation="portrait" xlink:href="12935_2023_3011_Fig3a_HTML.jpg"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e5092" position="float" orientation="portrait" xlink:href="12935_2023_3011_Fig3b_HTML.jpg"/></fig><table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Distribution of HPV16 and HPV18 variants in different cervical cytology grades</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1"/><th align="left" colspan="4" rowspan="1">Cervical cytology</th></tr><tr><th align="left" colspan="1" rowspan="1">Normal</th><th align="left" colspan="1" rowspan="1">LSIL</th><th align="left" colspan="1" rowspan="1">HSIL</th><th align="left" colspan="1" rowspan="1">SCC/ADC</th></tr><tr><th align="left" colspan="4" rowspan="1">N (%)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">HPV16 lineage</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A1</td><td align="left" colspan="1" rowspan="1">3 (25)</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A2</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">3 (25)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A4</td><td align="left" colspan="1" rowspan="1">3 (25)</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">5 (41.7)</td><td align="left" colspan="1" rowspan="1">3 (25)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;C1</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;D1</td><td align="left" colspan="1" rowspan="1">5 (41.7)</td><td align="left" colspan="1" rowspan="1">8 (66.7)</td><td align="left" colspan="1" rowspan="1">3 (25)</td><td align="left" colspan="1" rowspan="1">6 (50)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;D2</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">HPV18 lineage</td><td align="left" colspan="4" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A1</td><td align="left" colspan="1" rowspan="1">5 (41.7)</td><td align="left" colspan="1" rowspan="1">6 (50)</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A3</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">3 (25)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A4</td><td align="left" colspan="1" rowspan="1">4 (33.3)</td><td align="left" colspan="1" rowspan="1">5 (41.70</td><td align="left" colspan="1" rowspan="1">7 (58.3)</td><td align="left" colspan="1" rowspan="1">7 (58.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;A5</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">2 (16.7)</td><td align="left" colspan="1" rowspan="1">1 (8.3)</td></tr></tbody></table></table-wrap></p><p id="Par37">Nucleotide variations in the E6 gene were observed in 12 HPV16 isolates (25%) when compared to the reference sequences of each sublineage. New SNPs detected in the studied HPV16 isolates from Iranian patients included A131G (A1), A131C (A4), A135C (A4), T178A (A1), T183G (A4), T286T (D1), T295G (A2), and A442C (A1 and A4). The remaining substitutions at the positions of A286T (D1) and T335C (D1) detected in three isolates were found to be silent mutations (Table <xref rid="Tab3" ref-type="table">3</xref>). In addition, amino acid changes in the E6 gene had occurred in 45 isolates (93.75%). L83V was the most common amino acid change (58.33%), followed by Q14H/D (50%) and H78Y (47.91%) (Table <xref rid="Tab3" ref-type="table">3</xref>). Among HPV18 isolates, eight new SNPs were detected throughout the E6 gene including T149C (A1), C153T (A5), G287C (A4), T485T (A5), C549C (A5), and C554T (A1), all of which were silent mutations except for T317G (A1) and T382G (A1) which were found to be missense mutations. Furthermore, amino acid changes in the E6 gene had occurred in 10 HPV18 isolates (20.83%) among which, the most common amino acid change was E33G (16.66%), followed by F71L (2.1%) and L93R (2.1%) (Table <xref rid="Tab4" ref-type="table">4</xref>). No deletions or insertions were found in any of the HPV16 or 18 E6 genes.</p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par38">This is the first investigation of the presence of HPV types in a large-scale screen of liquid-based cytology samples from Iranian population in the southwest. The study population was comprised of gynecological outpatients including symptomatic and asymptomatic women. The vast majority of Iranian published data include FFPE tissue specimens in hospitals and research centers. However, the current study focused on ThinPrep cytology samples from patients in Shiraz, the capital city of Fars Province. In this study, the overall HPV-positive rate was 62.19%, a rate similar to but slightly higher than that in a recent cross-sectional retrospective study (52.25%) by Rezaee Azhar et al. on female outpatients referred to the medical laboratories of Tehran Metropolitan, Iran [<xref ref-type="bibr" rid="CR33">33</xref>]. Previously, in the largest Iranian study including 10,266 samples collected from 31 Iranian provinces, Mobini Kesheh et al. found 45.9% (n&#8201;=&#8201;8351) of women positive for HPV DNA [<xref ref-type="bibr" rid="CR20">20</xref>]. Reports from different parts of the world indicate an overall HPV prevalence ranging from 9.9 to 49.1% [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Furthermore, consistent with previously published reports from Iran, the prevalence of HPV has been reported to range from 5.5 to 9.4% in normal cytology specimens, 61.7 to 65.3% in CIN I&#8211;III specimens, and 75.2 to 87% in CC specimens with various study populations and methodologies [<xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR32">32</xref>]. In our study, HPV prevalence in normal, ASC-US, ASC-H, LSIL, and HSIL cervical cytology samples were 48.9%, 93.6%, 100%, 100%, and 100%, respectively which appeared to be higher than not only the overall prevalence previously reported in Iran, but also previous reports from regional countries and most of other countries worldwide [<xref ref-type="bibr" rid="CR40">40</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref>]. On the other hand, the prevalence of HPV infection in the present study is consistent with a study by Schmit et al. [<xref ref-type="bibr" rid="CR8">8</xref>] reporting the presence of any of 51 investigated genital HPV types in 33.3%, 83.1%, 98.2%, and 100% of normal, ASC-US, LSIL, and HSIL cervical cytology samples, respectively. Taken together, the present study obviously shows that the prevalence of HPV infection in the southwest of Iran is high. This may be due to the fact that this study was cross-sectional and since HPV infections can be transient and cleared up by the immune system, the prevalence of HPV may accordingly change over time. Furthermore, there is evidence that the distribution of HPV types varies by region and ethnicity [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>] which might be another explanation&#160;for the current finding. In addition, many of the differences observed in the prevalence of HPV infections among different studies can be attributable to the methodological differences in the PCR-based assays used including the size of the PCR product, primer sets, reaction conditions, the efficiency of the polymerase enzyme, the potential of the HPV DNA spectrum amplified to detect multiple types,&#160;and even the type (frozen/FFPE/cytology specimens) and quality of the clinical specimens, causing variations in the specificity and sensitivity of the assays [<xref ref-type="bibr" rid="CR46">46</xref>]. Herein, we have used methodological assays that are among the few ones capable of detecting 40 HPV types including HR-HPVs, pHR-HPVs, and LR-HPVs, and are also more sensitive than those used in previous studies in the region, allowing the identification of HPV types in specimens with low viral loads. HPV infection is responsible for almost 100% of cervical SCCs. The underestimation of HPV prevalence in most reports is attributable to the technical limitations of the corresponding studies [<xref ref-type="bibr" rid="CR47">47</xref>]. However, the possibility of bias in the&#160;estimation&#160;of HPV prevalence should be taken into account since to date, Iran&#160;has not&#160;had an organized national and regular CC screening program and the cervical samples evaluated in this study were collected only from the referred volunteer outpatients attending routine gynecological visits for cytology-based screening which could not have reflected the real virus epidemiology among the general population.</p><p id="Par39">In the present study, the five most prevalent HR-HPV types in ThinPrep cytology samples were HPV16 (17.6%), 56 (12.6%), 66 (12%), 52 (9.9%), and 18 (8.7%) which comprised 61% of the total HR-HPV-positive samples. In addition, HPV6 (45.6%), 81 (9.2%), and 11 (7.4%) were found to be the most dominant LR-HPV types. In the largest study ever conducted in Iran, the most common HPV types reported by Mobini Kesheh et al. were HPV6 (43.3%), HPV16 (16.6%), HPV11 (11.4%), and HPV52 (9.6%) [<xref ref-type="bibr" rid="CR20">20</xref>]. Another study reported the five most common types to be HPV6, HPV11, HPV16, HPV51, and HPV53 [<xref ref-type="bibr" rid="CR48">48</xref>]. In a study by Bitarafan et al. on 12,076 Iranian women, the five most common HR-HPV types were as follows: HPV16 (16.98%), HPV52 (8.8%), HPV18 (7.69%), HPV39 (7.63%), and HPV31 (7.45%) [<xref ref-type="bibr" rid="CR19">19</xref>]. The most similar results to our study reported from Iran were those by Rezaee Azhar et al. revealing HPV16 (12%), 66 (7%), 18 (6%), 31 (5%), and 52 (5%) as the five most prevalent HR-HPV types and HPV6 (32%) and 11 (6%) as the most prevalent LR-HPV types [<xref ref-type="bibr" rid="CR33">33</xref>]. Interestingly, we found HPV81, a rarely reported type from Iran, to be the second most prevalent LR-HPV type and detected HPV90 and 87, first reported types in Iran, in women with both normal and abnormal cytology; a finding that is consistent with two studies from Qatar, one of the nearest neighboring countries&#160;to Fars province in Iran, which reported HPV81, 90, and 11 as the most prevalent LR-HPV types among Arab women [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The current finding is another piece of evidence indicating that the geographic distributions of HPV types vary greatly. Given that current HPV vaccines only confer protection against certain HPV types, regional variations in the distribution of HPV types can alter the effectiveness of vaccination. Accordingly, the investigation of HPV distribution patterns can be critical to the development and application of HPV vaccines. In Iran, the 2-valent and 4-valent vaccines are not currently included in the national vaccination program. Furthermore, although the 9-valent vaccine has been approved by the Ministry of Food and Drug Safety and is available as a non-national immunization program vaccine, it does not provide immunity against the HR-HPV types 35, 39, 51, 56, 59, 66, and 68, some of which are highly prevalent in our population. On the other hand, given the implication of HPV in multiple types of cancer aside from CC, including head and neck carcinomas and esophageal carcinoma which is among the most common malignancies in the Iranian population [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>], the development of novel vaccines with the potential for immunization against major circulating HR-HPV types in the region including 56, 59, 66, and 68 deserves special consideration.</p><p id="Par40">Unlike single infections, multiple HPV infections have been reported to be associated with increased risk of high-grade lesions and cancer [<xref ref-type="bibr" rid="CR52">52</xref>]. Therefore, investigating the prevalence and patterns of multiple HPV infections can provide a better understanding of their role in carcinogenesis and the prognosis of patients with persistent infection. A study by Lee et al. has reported an association between multiple HPV infections and an increased risk of CC [<xref ref-type="bibr" rid="CR53">53</xref>]. Further, Schmitt et al. have reported that HPV co-infection lengthens the course of infection [<xref ref-type="bibr" rid="CR54">54</xref>]. In line with previously reported studies [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], patients with cytological findings of ASC-US, ASC-H, LSIL, and HSIL showed higher multiple HR-HPV-positive rates (89.1%) than women with normal cytological results (66.8%). Cytological findings have shown high rates of multiple HR-HPV infections in low-grade as well as high-grade lesions, suggesting that multiple HR-HPV infections are associated with all stages of cervical lesions. These results are consistent with those of other cross-sectional and prospective studies [<xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par41">Data on HPV variants are of value in HPV diagnosis, developing vaccines, and therapeutic approaches to control virus-induced pathological damage. The oncogenicity of different HPV variants may vary among different populations with distinct distribution of human leukocyte antigens (HLA) alleles [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. To our knowledge, this&#160;is the first study characterizing genetic variations in the E6 gene region of HPV16 and 18 variants simultaneously, in normal, LSIL, HSIL, and CC specimens from women living in the southwest of Iran. Given the critical role of E6 gene in cell immortalization and malignancy, it was selected for the classification of the intra-typic HPV16 and HPV18 variants. In the current work, D1 followed by A4 sublineages were found to be the major HPV16 variants which is in line with previous studies from other parts of Iran [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Moreover, we were able to identify A1, A2, and C1 sublineages which were not previously detected simultaneously in either of the two previous studies from Iran. We also identified 10 new nucleotide substitutions in the sequence of HPV16 E6 gene which were not previously reported in the country and accordingly submitted to GenBank. When aligned&#160;with E6 gene sequences available in the database, we noticed that all of the detected substitutions were previously reported by other investigators especially from Asia.</p><p id="Par42">There is strong evidence that HPV16 lineage D is associated with CIN3&#8201;+&#8201;with threefold higher risk than lineage A. It is also associated with a higher risk of persistent infection, invasive and glandular high-grade lesions, and CC development than lineage A [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. In addition, HPV16 lineage D infection results in higher rates of genomic integration compared to other HPV16 lineages [<xref ref-type="bibr" rid="CR62">62</xref>]. Due to the high prevalence of HPV16 lineage D variants in the Iranian papulation, it seems that they are most likely at high&#160;risk of cancer&#160;development and progression which necessitates an immediate action for HPV vaccination. With regard to the distribution of HPV18 sublineages, A4 was the most frequent sublineage detected in the current study. This finding is consistent with the results of two previous studies which also reported HPV18 A4 sublineage to be the predominant variant in Iran [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. However, there is a single study from Iran reporting A3 as the most prevalent sublineage in the country [<xref ref-type="bibr" rid="CR21">21</xref>]. In general, our finding is in line with the global distribution pattern of HPV18 variants with a predominance of the A lineage in most parts of the world except sub-Saharan Africa. More specifically, A3 and A4 sublineages strongly predominate in South/Central Asia, northern Africa, Europe, and South/Central America [<xref ref-type="bibr" rid="CR17">17</xref>]. While the majority of A5 isolates have been detected in Africa [<xref ref-type="bibr" rid="CR17">17</xref>], this sublineage was also detected in our study and previously reported by another study in Iran [<xref ref-type="bibr" rid="CR23">23</xref>] and a study in Saudi Arabia [<xref ref-type="bibr" rid="CR63">63</xref>] which shares a maritime border with Iran. Previous studies have suggested that the distribution of HPV18 variants is different between ADC and SCC cases [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. However, due to the small number of HPV18-positive ADC cases included in our study, no significant difference in HPV18 variant distribution was observed between ADC and SCC cases. On the other hand, in a study with a larger sample size including 81 ADC cases, each matched with two SCC cases in terms of country and age, no difference in HPV18 variant distribution, either overall or in any of the regions, was found [<xref ref-type="bibr" rid="CR17">17</xref>]. In our population, eight substitutions were found in HPV18 variants which were not previously reported in the country. Following further examination, we found these mutations previously reported by Korean researchers [<xref ref-type="bibr" rid="CR18">18</xref>], a finding that supports the geographical distribution of HPV lineages. Previous studies have found that HPV18 lineage B could be associated with a higher risk of CC than lineage A, and a higher risk of persistence and progression [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. In contrast, other studies have reported that no significant difference was observed in the risk of pre-invasive lesions among HPV18 lineages (A, B, and C) [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Since we did not detect any non-A lineages of HPV18 in our study, it was not feasible to analyze the relationship between HPV18 lineages and the risk of cervical pre-invasive&#160;and invasive lesions. However, our study revealed no statistically significant association between HPV18 A lineage and cervical lesions in Iran. This result may have been affected by the small sample size of HPV18-related cervical lesions in our study.</p><p id="Par43">Generally, the present work had a few limitations, the most important of which was recruiting patients from a single center. In order to confirm the results of this study, multicenter studies are required. Further, since the results from cross-sectional studies may be misleading, longitudinal studies with focus on persistent infections with each specific HPV type need to be performed to further investigate the role of each HPV type in CC development. In addition, the considerable difference observed in the frequency of different HPV types among former studies highlights the need for further investigations to provide additional information on the geographical distribution of HPV types and variants in Iran over time using standard methodological techniques for HPV detection and typing. Such data can help to decide upon the best diagnostic and therapeutic approaches, evaluate the efficiency of currently used vaccines, and develop new generations of them.</p></sec><sec id="Sec13"><title>Conclusions</title><p id="Par44">To sum up, the present study suggests that the prevalence of HPV infection in women of all age groups with or without premalignant lesions in the southwestern Iran is high. Our data also show that the predominant HPV types in the southwest of Iran may differ from those detected in other parts of the country. Findings from this study illustrate the necessity of initiating HPV vaccination for the general population and developing national cervical screening programs as well as targeted education to the younger population in order to encourage the application of infection control measures. Moreover, the identification of emerging HPV types that are not covered even by the new 9-valent HPV vaccine raises awareness about potentially important HPV variants. Regarding the approach to cervical screening for cancerous and precancerous lesions in the region, it is best to use a combination of thinPrep cytology test and HPV detection assays in order to&#160;improve the accuracy of the screening. Finally, accurate data on the geographic distribution of different HPV types and HPV16/18 variants can be beneficial for developing diagnostic probes and targeted HPV vaccines for Iranian populations.</p></sec><sec sec-type="supplementary-material"><sec id="Sec14"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12935_2023_3011_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 1</bold>: <bold>Table S1.</bold> The sequences of primers used for the amplification of HPV16 and HPV18 E6 gene. <bold>Table S2.</bold> HPV16 sublineages based on distinguishing positions in E6 gene region. <bold>Table 3.</bold> HPV18 sublineages based on distinguishing positions in E6 gene region. <bold>Fig. S1. </bold>A representative reverse line blot HPV genotyping test strip using AMPLIQUALITY HPV-TYPE EXPRESS kit showing colored bands corresponding to HPV6 and 56. The strip is coated with a staining control band, an amplification control of the housekeeping thiosulfate sulfurtransferase (TST) gene band, and a universal HPV band. <bold>Fig. S2. </bold>Direct DNA Sanger sequencing chromatogram showing a sequence polymorphism (highlighted in blue) in E6 gene region of HPV16 lineage A1 isolate HAM14 (GenBank accession Number: OP572428). <bold>Fig. S3. </bold>Direct DNA Sanger sequencing chromatogram showing a sequence polymorphism (highlighted in blue) in E6 gene region of HPV16 lineage A4 isolate HAM27 (GenBank accession Number: OP572441). <bold>Fig. S4. </bold>Direct DNA Sanger sequencing chromatogram showing a sequence polymorphism (highlighted in blue) in E6 gene region of HPV16 lineage A2 isolate HAM40 (GenBank accession Number: OP572454). <bold>Fig. S5. </bold>Direct DNA Sanger sequencing chromatogram showing a sequence polymorphism (highlighted in blue) in E6 gene region of HPV18 lineage A1 isolate HAM62 (GenBank accession Number: OP572476). <bold>Fig. S6. </bold>Direct DNA Sanger sequencing chromatogram showing a sequence polymorphism (highlighted in blue) in E6 gene region of HPV18 lineage A1 isolate HAM77 (GenBank accession Number: OP572491) iosulfate sulfurtransferase (TST) gene band, and a universal HPV band.</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADC</term><def><p id="Par5">Adenocarcinoma</p></def></def-item><def-item><term>ASC</term><def><p id="Par6">Atypical squamous cell</p></def></def-item><def-item><term>ASC-H</term><def><p id="Par7">Atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion</p></def></def-item><def-item><term>ASC-US</term><def><p id="Par8">Atypical squamous cells of undetermined significance</p></def></def-item><def-item><term>CC</term><def><p id="Par9">Cervical cancer</p></def></def-item><def-item><term>CIN</term><def><p id="Par10">Cervical intraepithelial neoplasia</p></def></def-item><def-item><term>FFPE</term><def><p id="Par11">Formalin-fixed paraffin-embedded</p></def></def-item><def-item><term>HSIL</term><def><p id="Par12">High-grade squamous intraepithelial lesion</p></def></def-item><def-item><term>HPV</term><def><p id="Par13">Human papillomavirus</p></def></def-item><def-item><term>HR-HPV</term><def><p id="Par14">High-risk HPV</p></def></def-item><def-item><term>LR-HPV</term><def><p id="Par15">Low-risk HPV</p></def></def-item><def-item><term>LSIL</term><def><p id="Par16">Low-grade squamous intraepithelial lesion</p></def></def-item><def-item><term>pHR-HPV</term><def><p id="Par17">Possible high-risk</p></def></def-item><def-item><term>SCC</term><def><p id="Par18">Squamous cell carcinoma</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to thank the staff at Shahid Motahari Clinic affiliated with Shiraz University of Medical Sciences for their collaboration.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>AF conceptualized and supervised the project, performed the methodology and prepared the original draft. HA performed the methodology and phylogenetic analysis. MAO performed the methodology. BG collaborated as consultant pathologists. ABB provided resources and administered the study. CPP visualized the study and edited the manuscript. NN performed the methodology and sample collection. SN carried out the statistical analysis and data interpretation, reviewed and edited the manuscript. All authors reviewed the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was financially supported by Research Council of Shiraz University of Medical Science under Grant numbers: 25198 and 25199.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analysed during this study are included in this published article and its supplementary information files.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par45">The procedures of this study were approved by the Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.REC.1400.891 and IR.SUMS.REC.1400.892). Written informed consent for research purposes was obtained from all participants.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par46">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>H</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries</article-title><source>CA Cancer J Clin</source><year>2021</year><volume>71</volume><issue>3</issue><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">33538338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21660</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rezaianzadeh</surname><given-names>A</given-names></name><name name-style="western"><surname>Dehghani</surname><given-names>SL</given-names></name><name name-style="western"><surname>Mousavi</surname><given-names>M</given-names></name><name name-style="western"><surname>Rezaeianzadeh</surname><given-names>R</given-names></name></person-group><article-title>The incidence of uterus cancer in Iran: a systematic review</article-title><source>WHB</source><year>2017</year><volume>4</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghalavandi</surname><given-names>S</given-names></name><name name-style="western"><surname>Zarei</surname><given-names>F</given-names></name><name name-style="western"><surname>Heidarnia</surname><given-names>A</given-names></name><name name-style="western"><surname>Beiranvand</surname><given-names>R</given-names></name></person-group><article-title>A blended educational intervention program on Pap-test related behavior among Iranian women</article-title><source>Reprod Health</source><year>2021</year><volume>18</volume><issue>1</issue><fpage>228</fpage><pub-id pub-id-type="pmid">34774076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12978-021-01281-x</pub-id><pub-id pub-id-type="pmcid">PMC8590270</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burd</surname><given-names>EM</given-names></name></person-group><article-title>Human papillomavirus and cervical cancer</article-title><source>Clin Microbiol Rev</source><year>2003</year><volume>16</volume><issue>1</issue><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">12525422</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.16.1.1-17.2003</pub-id><pub-id pub-id-type="pmcid">PMC145302</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schledermann</surname><given-names>D</given-names></name><name name-style="western"><surname>Ejersbo</surname><given-names>D</given-names></name><name name-style="western"><surname>Hoelund</surname><given-names>B</given-names></name></person-group><article-title>Improvement of diagnostic accuracy and screening conditions with liquid-based cytology</article-title><source>Diagn Cytopathol</source><year>2006</year><volume>34</volume><issue>11</issue><fpage>780</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">17041948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/dc.20515</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiffman</surname><given-names>M</given-names></name><name name-style="western"><surname>Clifford</surname><given-names>G</given-names></name><name name-style="western"><surname>Buonaguro</surname><given-names>FM</given-names></name></person-group><article-title>Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline</article-title><source>Infect Agents Cancer</source><year>2009</year><volume>4</volume><fpage>8</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1750-9378-4-8</pub-id><pub-id pub-id-type="pmcid">PMC2694995</pub-id><pub-id pub-id-type="pmid">19486508</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Bruni L, Albero G, Serrano B, Mena M, G&#243;mez D, Mu&#241;oz J, Bosch F, de Sanjos&#233; S. Human papillomavirus and related diseases in the world&#8212;summary report 22 October 2021. ICO HPV Information Centre: Barcelona, Spain. 2021.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmitt</surname><given-names>M</given-names></name><name name-style="western"><surname>Depuydt</surname><given-names>C</given-names></name><name name-style="western"><surname>Benoy</surname><given-names>I</given-names></name><name name-style="western"><surname>Bogers</surname><given-names>J</given-names></name><name name-style="western"><surname>Antoine</surname><given-names>J</given-names></name><name name-style="western"><surname>Arbyn</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence and viral load of 51 genital human papillomavirus types and three subtypes</article-title><source>Int J Cancer</source><year>2013</year><volume>132</volume><issue>10</issue><fpage>2395</fpage><lpage>2403</lpage><pub-id pub-id-type="pmid">23034864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.27891</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoa Assoumou</surname><given-names>S</given-names></name><name name-style="western"><surname>NdjoyiMbiguino</surname><given-names>A</given-names></name><name name-style="western"><surname>Mabika Mabika</surname><given-names>B</given-names></name><name name-style="western"><surname>NguiziOgoula</surname><given-names>S</given-names></name><name name-style="western"><surname>El Mzibri</surname><given-names>M</given-names></name><name name-style="western"><surname>Khattabi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities</article-title><source>Infect Agents Cancer</source><year>2016</year><volume>11</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13027-016-0046-0</pub-id><pub-id pub-id-type="pmcid">PMC4714494</pub-id><pub-id pub-id-type="pmid">26779280</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doorbar</surname><given-names>J</given-names></name><name name-style="western"><surname>Quint</surname><given-names>W</given-names></name><name name-style="western"><surname>Banks</surname><given-names>L</given-names></name><name name-style="western"><surname>Bravo</surname><given-names>IG</given-names></name><name name-style="western"><surname>Stoler</surname><given-names>M</given-names></name><name name-style="western"><surname>Broker</surname><given-names>TR</given-names></name><etal/></person-group><article-title>The biology and life-cycle of human papillomaviruses</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><issue>Suppl 5</issue><fpage>F55</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">23199966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2012.06.083</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Sanjose</surname><given-names>S</given-names></name><name name-style="western"><surname>Quint</surname><given-names>WG</given-names></name><name name-style="western"><surname>Alemany</surname><given-names>L</given-names></name><name name-style="western"><surname>Geraets</surname><given-names>DT</given-names></name><name name-style="western"><surname>Klaustermeier</surname><given-names>JE</given-names></name><name name-style="western"><surname>Lloveras</surname><given-names>B</given-names></name><etal/></person-group><article-title>Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study</article-title><source>Lancet Oncol</source><year>2010</year><volume>11</volume><issue>11</issue><fpage>1048</fpage><lpage>1056</lpage><pub-id pub-id-type="pmid">20952254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1470-2045(10)70230-8</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Sanjos&#233;</surname><given-names>S</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>M</given-names></name><name name-style="western"><surname>Castellsagu&#233;</surname><given-names>X</given-names></name><name name-style="western"><surname>Clifford</surname><given-names>G</given-names></name><name name-style="western"><surname>Bruni</surname><given-names>L</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>N</given-names></name><etal/></person-group><article-title>Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis</article-title><source>Lancet Infect Dis</source><year>2007</year><volume>7</volume><issue>7</issue><fpage>453</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">17597569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(07)70158-5</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burk</surname><given-names>RD</given-names></name><name name-style="western"><surname>Harari</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name></person-group><article-title>Human papillomavirus genome variants</article-title><source>Virology</source><year>2013</year><volume>445</volume><issue>1&#8211;2</issue><fpage>232</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">23998342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.virol.2013.07.018</pub-id><pub-id pub-id-type="pmcid">PMC3979972</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>JS</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>EC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JE</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YB</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea</article-title><source>APMIS</source><year>2016</year><volume>124</volume><issue>11</issue><fpage>950</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">27546189</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/apm.12592</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clifford</surname><given-names>GM</given-names></name><name name-style="western"><surname>Tenet</surname><given-names>V</given-names></name><name name-style="western"><surname>Georges</surname><given-names>D</given-names></name><name name-style="western"><surname>Alemany</surname><given-names>L</given-names></name><name name-style="western"><surname>Pav&#243;n</surname><given-names>MA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women</article-title><source>Papillomavirus Res</source><year>2019</year><volume>7</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">30738204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pvr.2019.02.001</pub-id><pub-id pub-id-type="pmcid">PMC6374642</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hang</surname><given-names>D</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Xie</surname><given-names>S</given-names></name><etal/></person-group><article-title>Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population</article-title><source>Virology</source><year>2016</year><volume>488</volume><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">26650690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.virol.2015.11.016</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>AA</given-names></name><name name-style="western"><surname>Gheit</surname><given-names>T</given-names></name><name name-style="western"><surname>Franceschi</surname><given-names>S</given-names></name><name name-style="western"><surname>Tommasino</surname><given-names>M</given-names></name><name name-style="western"><surname>Clifford</surname><given-names>GM</given-names></name></person-group><article-title>Human papillomavirus 18 genetic variation and cervical cancer risk worldwide</article-title><source>J Virol</source><year>2015</year><volume>89</volume><issue>20</issue><fpage>10680</fpage><lpage>10687</lpage><pub-id pub-id-type="pmid">26269181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.01747-15</pub-id><pub-id pub-id-type="pmcid">PMC4580183</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>N</given-names></name><name name-style="western"><surname>Park</surname><given-names>JS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JE</given-names></name><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>H</given-names></name><name name-style="western"><surname>Roh</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea: Korean HPV18 variants and clinical manifestation</article-title><source>Virol J</source><year>2020</year><volume>17</volume><issue>1</issue><fpage>70</fpage><pub-id pub-id-type="pmid">32448303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12985-020-01337-7</pub-id><pub-id pub-id-type="pmcid">PMC7245819</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bitarafan</surname><given-names>F</given-names></name><name name-style="western"><surname>Hekmat</surname><given-names>MR</given-names></name><name name-style="western"><surname>Khodaeian</surname><given-names>M</given-names></name><name name-style="western"><surname>Razmara</surname><given-names>E</given-names></name><name name-style="western"><surname>Ashrafganjoei</surname><given-names>T</given-names></name><name name-style="western"><surname>Modares Gilani</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence and genotype distribution of human papillomavirus infection among 12,076 Iranian women</article-title><source>Int J Infect Dis</source><year>2021</year><volume>111</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">34343706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijid.2021.07.071</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MobiniKesheh</surname><given-names>M</given-names></name><name name-style="western"><surname>Keyvani</surname><given-names>H</given-names></name></person-group><article-title>The prevalence of HPV genotypes in Iranian population: an update</article-title><source>Iran J Pathol</source><year>2019</year><volume>14</volume><issue>3</issue><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">31582996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.30699/ijp.2019.90356.1861</pub-id><pub-id pub-id-type="pmcid">PMC6742734</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MobiniKesheh</surname><given-names>M</given-names></name><name name-style="western"><surname>Barazandeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaffashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Shahkarami</surname><given-names>MK</given-names></name><name name-style="western"><surname>Nadji</surname><given-names>SA</given-names></name></person-group><article-title>Genetic diversity of HPV 16 and HPV 18 based on partial long control region in Iranian women</article-title><source>Can J Infect Dis Med Microbiol</source><year>2022</year><volume>2022</volume><fpage>4759871</fpage><pub-id pub-id-type="pmid">35126798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/4759871</pub-id><pub-id pub-id-type="pmcid">PMC8808245</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadat Larijani</surname><given-names>M</given-names></name><name name-style="western"><surname>Omrani</surname><given-names>MD</given-names></name><name name-style="western"><surname>Soleimani</surname><given-names>R</given-names></name><name name-style="western"><surname>Bavand</surname><given-names>A</given-names></name><name name-style="western"><surname>Nejadeh</surname><given-names>AH</given-names></name><name name-style="western"><surname>Ezzatizadeh</surname><given-names>V</given-names></name><etal/></person-group><article-title>Determination of human papillomavirus type 18 lineage of E6: a population study from Iran</article-title><source>Biomed Res Int</source><year>2022</year><volume>2022</volume><fpage>2839708</fpage><pub-id pub-id-type="pmid">35342765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/2839708</pub-id><pub-id pub-id-type="pmcid">PMC8956376</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salavatiha</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shoja</surname><given-names>Z</given-names></name><name name-style="western"><surname>Heydari</surname><given-names>N</given-names></name><name name-style="western"><surname>Marashi</surname><given-names>SM</given-names></name><name name-style="western"><surname>Younesi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nozarian</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Lineage analysis of human papillomavirus type 18 based on E6 region in cervical samples of Iranian women</article-title><source>J Med Virol.</source><year>2020</year><volume>92</volume><fpage>3815</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.26283</pub-id><pub-id pub-id-type="pmid">32644190</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaezi</surname><given-names>T</given-names></name><name name-style="western"><surname>Shoja</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hamkar</surname><given-names>R</given-names></name><name name-style="western"><surname>Shahmahmoodi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nozarian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Marashi</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Human papillomavirus type 16 lineage analysis based on E6 region in cervical samples of Iranian women</article-title><source>Infect Genet Evol</source><year>2017</year><volume>55</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">28847737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.meegid.2017.08.025</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safaei</surname><given-names>A</given-names></name><name name-style="western"><surname>Khanlari</surname><given-names>M</given-names></name><name name-style="western"><surname>Momtahen</surname><given-names>M</given-names></name><name name-style="western"><surname>Monabati</surname><given-names>A</given-names></name><name name-style="western"><surname>Robati</surname><given-names>M</given-names></name><name name-style="western"><surname>Amooei</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran</article-title><source>Indian J Pathol Microbiol</source><year>2010</year><volume>53</volume><issue>4</issue><fpage>681</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">21045392</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0377-4929.72030</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghaffari</surname><given-names>SR</given-names></name><name name-style="western"><surname>Sabokbar</surname><given-names>T</given-names></name><name name-style="western"><surname>Mollahajian</surname><given-names>H</given-names></name><name name-style="western"><surname>Dastan</surname><given-names>J</given-names></name><name name-style="western"><surname>Ramezanzadeh</surname><given-names>F</given-names></name><name name-style="western"><surname>Ensani</surname><given-names>F</given-names></name><etal/></person-group><article-title>Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran</article-title><source>Asian Pac J Cancer Prev</source><year>2006</year><volume>7</volume><issue>4</issue><fpage>529</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">17250423</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malary</surname><given-names>M</given-names></name><name name-style="western"><surname>Moosazadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Hamzehgardeshi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Afshari</surname><given-names>M</given-names></name><name name-style="western"><surname>Moghaddasifar</surname><given-names>I</given-names></name><name name-style="western"><surname>Afsharimoghaddam</surname><given-names>A</given-names></name></person-group><article-title>The prevalence of cervical human papillomavirus infection and the most at-risk genotypes among Iranian healthy women: a systematic review and meta-analysis</article-title><source>Int J Prev Med</source><year>2016</year><volume>7</volume><fpage>70</fpage><pub-id pub-id-type="pmid">27217936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/2008-7802.181756</pub-id><pub-id pub-id-type="pmcid">PMC4872517</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allameh</surname><given-names>T</given-names></name><name name-style="western"><surname>Moghim</surname><given-names>S</given-names></name><name name-style="western"><surname>Asadi-Zeidabadi</surname><given-names>M</given-names></name></person-group><article-title>A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science</article-title><source>Arch Gynecol Obstet</source><year>2011</year><volume>284</volume><issue>6</issue><fpage>1509</fpage><lpage>1513</lpage><pub-id pub-id-type="pmid">21387088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00404-011-1863-4</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esmaeili</surname><given-names>M</given-names></name><name name-style="western"><surname>Bonyadi</surname><given-names>M</given-names></name><name name-style="western"><surname>Dastranj</surname><given-names>A</given-names></name><name name-style="western"><surname>Alizadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Melli</surname><given-names>MS</given-names></name><name name-style="western"><surname>Shobeiri</surname><given-names>MJ</given-names></name></person-group><article-title>HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran</article-title><source>Gynecol Obstet Invest</source><year>2008</year><volume>66</volume><issue>1</issue><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">18500169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000134917</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharbatdaran</surname><given-names>M</given-names></name><name name-style="western"><surname>Siadati</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeinalzadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Shafaei</surname><given-names>S</given-names></name><name name-style="western"><surname>Basirat</surname><given-names>Z</given-names></name><name name-style="western"><surname>Esmi</surname><given-names>A</given-names></name></person-group><article-title>The frequency of HPV 16 and 18 in cervical discharge by PCR in women with abnormal pap smear or biopsy</article-title><source>Iran J Pathol</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>17</fpage><lpage>20</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jalilvand</surname><given-names>S</given-names></name><name name-style="western"><surname>Shoja</surname><given-names>Z</given-names></name><name name-style="western"><surname>Nourijelyani</surname><given-names>K</given-names></name><name name-style="western"><surname>Tohidi</surname><given-names>HR</given-names></name><name name-style="western"><surname>Hamkar</surname><given-names>R</given-names></name></person-group><article-title>Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination</article-title><source>J Med Virol</source><year>2015</year><volume>87</volume><issue>2</issue><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">25156655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.24053</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortazavi</surname><given-names>S</given-names></name><name name-style="western"><surname>Zali</surname><given-names>M</given-names></name><name name-style="western"><surname>Raoufi</surname><given-names>M</given-names></name><name name-style="western"><surname>Nadji</surname><given-names>M</given-names></name><name name-style="western"><surname>Kowsarian</surname><given-names>P</given-names></name><name name-style="western"><surname>Nowroozi</surname><given-names>A</given-names></name></person-group><article-title>The prevalence of human papillomavirus in cervical cancer in Iran</article-title><source>Asian Pac J Cancer Prev</source><year>2002</year><volume>3</volume><issue>1</issue><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12718611</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>RezaeeAzhar</surname><given-names>I</given-names></name><name name-style="western"><surname>Yaghoobi</surname><given-names>M</given-names></name><name name-style="western"><surname>Mossalaeie</surname><given-names>MM</given-names></name><name name-style="western"><surname>KollaeeDarabi</surname><given-names>A</given-names></name><name name-style="western"><surname>Nejadeh</surname><given-names>AH</given-names></name><name name-style="western"><surname>Jamshidi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran., Iran</article-title><source>Infect Agents Cancer</source><year>2022</year><volume>17</volume><issue>1</issue><fpage>7</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13027-022-00421-7</pub-id><pub-id pub-id-type="pmcid">PMC8897875</pub-id><pub-id pub-id-type="pmid">35248145</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Nayar</surname><given-names>R</given-names></name><name name-style="western"><surname>Wilbur</surname><given-names>DC</given-names></name></person-group><source>The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes</source><year>2015</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farhadi</surname><given-names>A</given-names></name><name name-style="western"><surname>Behzad-Behbahani</surname><given-names>A</given-names></name><name name-style="western"><surname>Geramizadeh</surname><given-names>B</given-names></name><name name-style="western"><surname>Sekawi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rahsaz</surname><given-names>M</given-names></name><name name-style="western"><surname>Sharifzadeh</surname><given-names>S</given-names></name></person-group><article-title>High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma</article-title><source>J Med Virol</source><year>2014</year><volume>86</volume><issue>7</issue><fpage>1134</fpage><lpage>1144</lpage><pub-id pub-id-type="pmid">24700118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.23945</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pakdel</surname><given-names>F</given-names></name><name name-style="western"><surname>Farhadi</surname><given-names>A</given-names></name><name name-style="western"><surname>Pakdel</surname><given-names>T</given-names></name><name name-style="western"><surname>Andishe-Tadbir</surname><given-names>A</given-names></name><name name-style="western"><surname>Alavi</surname><given-names>P</given-names></name><name name-style="western"><surname>Behzad-Behbahani</surname><given-names>A</given-names></name><etal/></person-group><article-title>The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16(INK4a) and NF-&#954;B expression in head and neck squamous cell carcinomas in Southwestern Iran</article-title><source>Braz J Microbiol</source><year>2021</year><volume>52</volume><issue>1</issue><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">33169334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s42770-020-00391-1</pub-id><pub-id pub-id-type="pmcid">PMC7966695</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Stecher</surname><given-names>G</given-names></name><name name-style="western"><surname>Tamura</surname><given-names>K</given-names></name></person-group><article-title>MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets</article-title><source>Mol Biol Evol.</source><year>2016</year><volume>33</volume><issue>7</issue><fpage>1870</fpage><lpage>1874</lpage><pub-id pub-id-type="pmid">27004904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/molbev/msw054</pub-id><pub-id pub-id-type="pmcid">PMC8210823</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papachristou</surname><given-names>E</given-names></name><name name-style="western"><surname>Sypsa</surname><given-names>V</given-names></name><name name-style="western"><surname>Paraskevis</surname><given-names>D</given-names></name><name name-style="western"><surname>Gkekas</surname><given-names>A</given-names></name><name name-style="western"><surname>Politi</surname><given-names>E</given-names></name><name name-style="western"><surname>Nicolaidou</surname><given-names>E</given-names></name><etal/></person-group><article-title>Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test</article-title><source>J Med Virol</source><year>2009</year><volume>81</volume><issue>12</issue><fpage>2059</fpage><lpage>2065</lpage><pub-id pub-id-type="pmid">19856480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.21639</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, et al. Human papillomavirus and related diseases in the world. Summary Report. 2019;17.</mixed-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bansal</surname><given-names>D</given-names></name><name name-style="western"><surname>Elmi</surname><given-names>AA</given-names></name><name name-style="western"><surname>Skariah</surname><given-names>S</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>P</given-names></name><name name-style="western"><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Al Hamadi</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Molecular epidemiology and genotype distribution of human papillomavirus (HPV) among Arab women in the State of Qatar</article-title><source>J Transl Med</source><year>2014</year><volume>12</volume><fpage>300</fpage><pub-id pub-id-type="pmid">25424736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-014-0300-4</pub-id><pub-id pub-id-type="pmcid">PMC4251937</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Lawati</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khamis</surname><given-names>FA</given-names></name><name name-style="western"><surname>Al-Hamdani</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Kalbani</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramadhan</surname><given-names>FA</given-names></name><name name-style="western"><surname>Al-Rawahi</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Prevalence of human papilloma virus in Oman: genotypes 82 and 68 are dominating</article-title><source>Int J Infect Dis</source><year>2020</year><volume>93</volume><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">31935539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijid.2019.12.038</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Youssef</surname><given-names>MA</given-names></name><name name-style="western"><surname>Abdelsalam</surname><given-names>L</given-names></name><name name-style="western"><surname>Harfoush</surname><given-names>RA</given-names></name><name name-style="western"><surname>Talaat</surname><given-names>IM</given-names></name><name name-style="western"><surname>Elkattan</surname><given-names>E</given-names></name><name name-style="western"><surname>Mohey</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test</article-title><source>Infect Agents Cancer</source><year>2016</year><volume>11</volume><fpage>6</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13027-016-0053-1</pub-id><pub-id pub-id-type="pmcid">PMC4756400</pub-id><pub-id pub-id-type="pmid">26889206</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name></person-group><article-title>Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women</article-title><source>Arch Gynecol Obstet.</source><year>2022</year><volume>308</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">35904609</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00404-022-06653-7</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montealegre</surname><given-names>JR</given-names></name><name name-style="western"><surname>Varier</surname><given-names>I</given-names></name><name name-style="western"><surname>Bracamontes</surname><given-names>CG</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>LM</given-names></name><name name-style="western"><surname>Guillaud</surname><given-names>M</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes</article-title><source>Ethn Health</source><year>2019</year><volume>24</volume><issue>7</issue><fpage>804</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">28870103</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13557858.2017.1373073</pub-id><pub-id pub-id-type="pmcid">PMC6185800</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montealegre</surname><given-names>JR</given-names></name><name name-style="western"><surname>Peckham-Gregory</surname><given-names>EC</given-names></name><name name-style="western"><surname>Marquez-Do</surname><given-names>D</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>L</given-names></name><name name-style="western"><surname>Guillaud</surname><given-names>M</given-names></name><name name-style="western"><surname>Adler-Storthz</surname><given-names>K</given-names></name><etal/></person-group><article-title>Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities</article-title><source>Gynecol Oncol</source><year>2018</year><volume>148</volume><issue>2</issue><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">29276057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2017.12.014</pub-id><pub-id pub-id-type="pmcid">PMC5801201</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>J</given-names></name><name name-style="western"><surname>Kostiuk</surname><given-names>M</given-names></name><name name-style="western"><surname>Biron</surname><given-names>VL</given-names></name></person-group><article-title>Molecular detection methods in HPV-related cancers</article-title><source>Front Oncol</source><year>2022</year><volume>12</volume><fpage>864820</fpage><pub-id pub-id-type="pmid">35574396</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.864820</pub-id><pub-id pub-id-type="pmcid">PMC9092940</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Sanjos&#233;</surname><given-names>S</given-names></name><name name-style="western"><surname>Serrano</surname><given-names>B</given-names></name><name name-style="western"><surname>Castellsagu&#233;</surname><given-names>X</given-names></name><name name-style="western"><surname>Brotons</surname><given-names>M</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>J</given-names></name><name name-style="western"><surname>Bruni</surname><given-names>L</given-names></name><etal/></person-group><article-title>Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries A WHO/ICO HPV Information Centre Report</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><issue>Suppl 4</issue><fpage>D1</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">23510764</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0264-410X(12)01435-1</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabet</surname><given-names>F</given-names></name><name name-style="western"><surname>Mosavat</surname><given-names>A</given-names></name><name name-style="western"><surname>Ahmadi Ghezeldasht</surname><given-names>S</given-names></name><name name-style="western"><surname>Basharkhah</surname><given-names>S</given-names></name><name name-style="western"><surname>Shamsian</surname><given-names>SAA</given-names></name><name name-style="western"><surname>Abbasnia</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran</article-title><source>Int J Infect Dis</source><year>2021</year><volume>103</volume><fpage>480</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">33310023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijid.2020.12.015</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elmi</surname><given-names>AA</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>D</given-names></name><name name-style="western"><surname>Acharya</surname><given-names>A</given-names></name><name name-style="western"><surname>Skariah</surname><given-names>S</given-names></name><name name-style="western"><surname>Dargham</surname><given-names>SR</given-names></name><name name-style="western"><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Human papillomavirus (HPV) infection: molecular epidemiology, genotyping, seroprevalence and associated risk factors among Arab Women in Qatar</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>1</issue><fpage>e0169197</fpage><pub-id pub-id-type="pmid">28046025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0169197</pub-id><pub-id pub-id-type="pmcid">PMC5207789</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khazaei</surname><given-names>S</given-names></name><name name-style="western"><surname>Ayubi</surname><given-names>E</given-names></name><name name-style="western"><surname>Mansori</surname><given-names>K</given-names></name><name name-style="western"><surname>Gholamaliee</surname><given-names>B</given-names></name><name name-style="western"><surname>Khazaei</surname><given-names>S</given-names></name><name name-style="western"><surname>KhosraviShadmani</surname><given-names>F</given-names></name><etal/></person-group><article-title>Geographic, sex and age distribution of esophageal cancer incidence in Iran: a population-based study</article-title><source>Middle East J Cancer</source><year>2017</year><volume>8</volume><issue>2</issue><fpage>103</fpage><lpage>108</lpage></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brouwer</surname><given-names>AF</given-names></name><name name-style="western"><surname>Eisenberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Meza</surname><given-names>R</given-names></name></person-group><article-title>Age effects and temporal trends in HPV-related and HPV-unrelated oral cancer in the United States: a multistage carcinogenesis modeling analysis</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>3</issue><fpage>e0151098</fpage><pub-id pub-id-type="pmid">26963717</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0151098</pub-id><pub-id pub-id-type="pmcid">PMC4786132</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monsonego</surname><given-names>J</given-names></name><name name-style="western"><surname>Zerat</surname><given-names>L</given-names></name><name name-style="western"><surname>Syrj&#228;nen</surname><given-names>K</given-names></name><name name-style="western"><surname>Zerat</surname><given-names>JC</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JS</given-names></name><name name-style="western"><surname>Halfon</surname><given-names>P</given-names></name></person-group><article-title>Prevalence of type-specific human papillomavirus infection among women in France: implications for screening, vaccination, and a future generation of multivalent HPV vaccines</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><issue>35</issue><fpage>5215</fpage><lpage>5221</lpage><pub-id pub-id-type="pmid">22713720</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2012.06.013</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SA</given-names></name><name name-style="western"><surname>Kang</surname><given-names>D</given-names></name><name name-style="western"><surname>Seo</surname><given-names>SS</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>JK</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>KY</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>YT</given-names></name><etal/></person-group><article-title>Multiple HPV infection in cervical cancer screened by HPVDNAChip</article-title><source>Cancer Lett</source><year>2003</year><volume>198</volume><issue>2</issue><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">12957357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0304-3835(03)00312-4</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmitt</surname><given-names>M</given-names></name><name name-style="western"><surname>Depuydt</surname><given-names>C</given-names></name><name name-style="western"><surname>Benoy</surname><given-names>I</given-names></name><name name-style="western"><surname>Bogers</surname><given-names>J</given-names></name><name name-style="western"><surname>Antoine</surname><given-names>J</given-names></name><name name-style="western"><surname>Arbyn</surname><given-names>M</given-names></name><etal/></person-group><article-title>Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities</article-title><source>J Clin Microbiol</source><year>2013</year><volume>51</volume><issue>5</issue><fpage>1458</fpage><lpage>1464</lpage><pub-id pub-id-type="pmid">23447632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.00087-13</pub-id><pub-id pub-id-type="pmcid">PMC3647930</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pista</surname><given-names>A</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>A</given-names></name><name name-style="western"><surname>Verdasca</surname><given-names>N</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>F</given-names></name></person-group><article-title>Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women</article-title><source>Clin Microbiol Infect</source><year>2011</year><volume>17</volume><issue>6</issue><fpage>941</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">21040156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1469-0691.2010.03387.x</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouh</surname><given-names>YT</given-names></name><name name-style="western"><surname>Cho</surname><given-names>HW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SM</given-names></name><name name-style="western"><surname>Min</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Song</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment</article-title><source>Obstet Gynecol Sci</source><year>2020</year><volume>63</volume><issue>5</issue><fpage>631</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">32693443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5468/ogs.20049</pub-id><pub-id pub-id-type="pmcid">PMC7494769</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrillo-Garc&#237;a</surname><given-names>A</given-names></name><name name-style="western"><surname>Ponce-de-Le&#243;n-Rosales</surname><given-names>S</given-names></name><name name-style="western"><surname>Cant&#250;-de-Le&#243;n</surname><given-names>D</given-names></name><name name-style="western"><surname>Fragoso-Ontiveros</surname><given-names>V</given-names></name><name name-style="western"><surname>Mart&#237;nez-Ram&#237;rez</surname><given-names>I</given-names></name><name name-style="western"><surname>Orozco-Col&#237;n</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer</article-title><source>Gynecol Oncol</source><year>2014</year><volume>134</volume><issue>3</issue><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">24979052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2014.06.018</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoshikawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yasugi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawana</surname><given-names>K</given-names></name><etal/></person-group><article-title>Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population</article-title><source>Cancer Lett</source><year>2000</year><volume>156</volume><issue>2</issue><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">10880765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0304-3835(00)00457-2</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pande</surname><given-names>S</given-names></name><name name-style="western"><surname>Jain</surname><given-names>N</given-names></name><name name-style="western"><surname>Prusty</surname><given-names>BK</given-names></name><name name-style="western"><surname>Bhambhani</surname><given-names>S</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name><etal/></person-group><article-title>Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><issue>3</issue><fpage>1060</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">18199779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.02202-07</pub-id><pub-id pub-id-type="pmcid">PMC2268386</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez</surname><given-names>S</given-names></name><name name-style="western"><surname>Cid</surname><given-names>A</given-names></name><name name-style="western"><surname>I&#241;arrea</surname><given-names>A</given-names></name><name name-style="western"><surname>Pato</surname><given-names>M</given-names></name><name name-style="western"><surname>Lamas</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Couso</surname><given-names>B</given-names></name><etal/></person-group><article-title>Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>8</issue><fpage>e104678</fpage><pub-id pub-id-type="pmid">25111834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0104678</pub-id><pub-id pub-id-type="pmcid">PMC4128731</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuna</surname><given-names>RE</given-names></name><name name-style="western"><surname>Moore</surname><given-names>WE</given-names></name><name name-style="western"><surname>Shanesmith</surname><given-names>RP</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>ST</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SS</given-names></name><name name-style="western"><surname>Schiffman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population</article-title><source>Int J Cancer</source><year>2009</year><volume>125</volume><issue>11</issue><fpage>2609</fpage><lpage>2613</lpage><pub-id pub-id-type="pmid">19569178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.24706</pub-id><pub-id pub-id-type="pmcid">PMC2757470</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lou</surname><given-names>H</given-names></name><name name-style="western"><surname>Boland</surname><given-names>JF</given-names></name><name name-style="western"><surname>Torres-Gonzalez</surname><given-names>E</given-names></name><name name-style="western"><surname>Albanez</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>MK</given-names></name><etal/></person-group><article-title>The D2 and D3 sublineages of human papilloma virus 16-positive cervical cancer in guatemala differ in integration rate and age of diagnosis</article-title><source>Cancer Res</source><year>2020</year><volume>80</volume><issue>18</issue><fpage>3803</fpage><lpage>3809</lpage><pub-id pub-id-type="pmid">32631904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-20-0029</pub-id><pub-id pub-id-type="pmcid">PMC7501218</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sait</surname><given-names>K</given-names></name><name name-style="western"><surname>Turki</surname><given-names>R</given-names></name><name name-style="western"><surname>Abuzenadah</surname><given-names>AM</given-names></name><name name-style="western"><surname>Jiffiri</surname><given-names>OH</given-names></name><name name-style="western"><surname>Bohmaidah</surname><given-names>A</given-names></name><name name-style="western"><surname>Sohrab</surname><given-names>SS</given-names></name></person-group><article-title>Genetic diversity and phylogenetic analysis of HPV 16 &amp; 18 variants isolated from cervical specimens of women in Saudi Arabia</article-title><source>Saudi J Biol Sci</source><year>2019</year><volume>26</volume><issue>2</issue><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">31485171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sjbs.2018.05.005</pub-id><pub-id pub-id-type="pmcid">PMC6717139</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burk</surname><given-names>RD</given-names></name><name name-style="western"><surname>Terai</surname><given-names>M</given-names></name><name name-style="western"><surname>Gravitt</surname><given-names>PE</given-names></name><name name-style="western"><surname>Brinton</surname><given-names>LA</given-names></name><name name-style="western"><surname>Kurman</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><issue>21</issue><fpage>7215</fpage><lpage>7220</lpage><pub-id pub-id-type="pmid">14612516</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lizano</surname><given-names>M</given-names></name><name name-style="western"><surname>Berumen</surname><given-names>J</given-names></name><name name-style="western"><surname>Guido</surname><given-names>MC</given-names></name><name name-style="western"><surname>Casas</surname><given-names>L</given-names></name><name name-style="western"><surname>Garc&#237;a-Carranc&#225;</surname><given-names>A</given-names></name></person-group><article-title>Association between human papillomavirus type 18 variants and histopathology of cervical cancer</article-title><source>J Natl Cancer Inst</source><year>1997</year><volume>89</volume><issue>16</issue><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">9274919</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/89.16.1227</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arroyo</surname><given-names>SL</given-names></name><name name-style="western"><surname>Basaras</surname><given-names>M</given-names></name><name name-style="western"><surname>Arrese</surname><given-names>E</given-names></name><name name-style="western"><surname>Hern&#225;ez</surname><given-names>S</given-names></name><name name-style="western"><surname>And&#237;a</surname><given-names>D</given-names></name><name name-style="western"><surname>Esteban</surname><given-names>V</given-names></name><etal/></person-group><article-title>Human papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao</article-title><source>Spain Virol J</source><year>2012</year><volume>9</volume><fpage>258</fpage><pub-id pub-id-type="pmid">23121839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-422X-9-258</pub-id><pub-id pub-id-type="pmcid">PMC3495774</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>DeSalle</surname><given-names>R</given-names></name><name name-style="western"><surname>Schiffman</surname><given-names>M</given-names></name><name name-style="western"><surname>Herrero</surname><given-names>R</given-names></name><name name-style="western"><surname>Burk</surname><given-names>RD</given-names></name></person-group><article-title>Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97</article-title><source>J Virol</source><year>2009</year><volume>83</volume><issue>3</issue><fpage>1443</fpage><lpage>1455</lpage><pub-id pub-id-type="pmid">19036820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.02068-08</pub-id><pub-id pub-id-type="pmcid">PMC2620887</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>